Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us

Marie Beaufrère, Bilade Cherqaoui and Félicie Costantino
The Journal of Rheumatology October 2025, 52 (10) 961-963; DOI: https://doi.org/10.3899/jrheum.2025-0809
Marie Beaufrère
1M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie Beaufrère
Bilade Cherqaoui
2B. Cherqaoui, MD, PhD, Pediatrics Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, France, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bilade Cherqaoui
Félicie Costantino
1M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Félicie Costantino
  • For correspondence: felicie.costantino{at}aphp.fr
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Brewerton DA,
    2. Hart FD,
    3. Nicholls A,
    4. Caffrey M,
    5. James DC,
    6. Sturrock RD.
    Ankylosing spondylitis and HL-A 27. Lancet 1973;1:904-7.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Breban M,
    2. Costantino F,
    3. André C,
    4. Chiocchia G,
    5. Garchon H-J.
    Revisiting MHC genes in spondyloarthritis. Curr Rheumatol Rep 2015;17:516.
    OpenUrlPubMed
  3. 3.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Landewé R, et al
    . The development of Assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Landewé R, et al
    . The Assessment of spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Ziade N,
    2. Maroof A,
    3. Elzorkany B, et al
    . What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back pain. Joint Bone Spine 2023;90:105579.
    OpenUrlPubMed
  6. 6.↵
    1. Deodhar A,
    2. Gill T,
    3. Magrey M.
    Human leukocyte antigen B27-negative axial spondyloarthritis: what do we know? ACR Open Rheumatol 2023;5:333-44.
    OpenUrlPubMed
  7. 7.↵
    1. Navarro-Compán V,
    2. Sepriano A,
    3. Capelusnik D,
    4. Baraliakos X.
    Axial spondyloarthritis. Lancet 2025;405:159-72.
    OpenUrlPubMed
  8. 8.↵
    1. Costantino F,
    2. Talpin A,
    3. Said-Nahal R, et al
    . Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis 2015;74:689-93.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Khan MA.
    HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995;7:263-9.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Bakland G,
    2. Alsing R,
    3. Singh K,
    4. Nossent JC.
    Assessment of spondyloarthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27. Arthritis Care Res 2013;65:448-53.
    OpenUrlCrossRef
  11. 11.↵
    1. Lim CSE,
    2. SenGupta R,
    3. Gaffney K.
    The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis. Rheumatology 2018;57:959-68.
    OpenUrlPubMed
  12. 12.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Khan MA,
    4. Braun J,
    5. Sieper J.
    How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004;63:535-43.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Bento da Silva A,
    2. Lourenço MH,
    3. Ramiro S, et al
    . Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis: a systematic literature review and meta-analysis. Rheumatology 2024;63:2923-37.
    OpenUrlPubMed
  14. 14.↵
    1. McDermott GC,
    2. Choufani M,
    3. Monshizadeh A,
    4. Ermann J.
    HLA-B27 testing in clinical practice: a retrospective analysis of testing indications and rheumatology referral patterns. J Rheumatol 2025;52:1021-7
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Brewerton DA,
    2. Caffrey M,
    3. Nicholls A,
    4. Walters D,
    5. James DC.
    Acute anterior uveitis and HL-A 27. Lancet 1973;302:994-6.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. van der Linden SM,
    2. Valkenburg HA,
    3. de Jongh BM,
    4. Cats A.
    The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241-9.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Peña JRA,
    2. Fung MK,
    3. Gandhi MJ.
    A review of laboratory practices using the HLA-B27 survey by the College of American Pathologists: how important is allele-level typing? Arch Pathol Lab Med 2024;148:149-54.
    OpenUrlPubMed
  18. 18.↵
    1. Bonnaud G,
    2. Aupetit C,
    3. Preux PM,
    4. Cogné M,
    5. Drouet M.
    Optimisation of HLA-B27 testing by association of flow cytometry and DNA typing. Clin Rheumatol 1999;18:23-7.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (10)
The Journal of Rheumatology
Vol. 52, Issue 10
1 Oct 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us
Marie Beaufrère, Bilade Cherqaoui, Félicie Costantino
The Journal of Rheumatology Oct 2025, 52 (10) 961-963; DOI: 10.3899/jrheum.2025-0809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us
Marie Beaufrère, Bilade Cherqaoui, Félicie Costantino
The Journal of Rheumatology Oct 2025, 52 (10) 961-963; DOI: 10.3899/jrheum.2025-0809
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • HLA-B27: a cornerstone in spondyloarthritis
    • Lessons learned from HLA-B27 referral patterns
    • HLA-B27 testing in clinical practice: when, how, and what next?
    • How to improve HLA-B27 use in clinical practice
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Confidence in the Use of Immunomodulatory Medications During Pregnancy: How Can Patient and Clinician Experience Be Improved?
  • Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action
  • Ample Room for Improvement
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire